Back
News

Brockton plans new sci-tech campus on Cambridge Science Park

Brockton Everlast has unveiled its vision for the transformation of Buildings 210-240 on Cambridge Science Park.

The plans come after the investor bought five buildings from L&G’s retail fund for £95m in February 2021.

Buildings 214 and 240, measuring a combined 50,000 sq ft, are vacant, having previously been occupied by Amgen, which has consolidated into Building 216. Buildings 210 and 211, totalling 25,000 sq ft, are lab-enabled and occupied by Excalibur Healthcare and Cambridge Glycoscience.

Start your free trial today

Your trusted daily source of commercial real estate news and analysis. Register now for unlimited digital access throughout April.

Including:

  • Breaking news, interviews and market updates
  • Expert legal commentary, market trends and case law
  • In-depth reports and expert analysis

Up next…